Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies

Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies

Saved in:

Bibliographic Details
Main Authors:	Ha-Lim Song, Min-Seok Kim, Woo-Young Cho, Ye-Seul Yoo, Jae-You Kim, Tae-Wook Kim, Hyori Kim, Dong-Hou Kim, Seung-Yong Yoon
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Series:	Molecular Neurodegeneration
Online Access:	https://doi.org/10.1186/s13024-024-00769-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson’s disease
by: Meryem Benmarce, et al.
Published: (2025-04-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

Extracellular Vesicle‐Mediated Delivery of 20S Proteasomes Enhances Tau Degradation in Recipient Cells
by: Jiseong Kim, et al.
Published: (2025-05-01)

Inhibition of tau neuronal internalization using anti-tau single domain antibodies
by: Clément Danis, et al.
Published: (2025-04-01)

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
by: Hyuk Sung Kwon, et al.
Published: (2025-03-01)

Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
by: Abdolhossein Zare, et al.
Published: (2025-07-01)

Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology.
by: Laura Vegas-Gomez, et al.
Published: (2025-01-01)

Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology
by: Laura Vegas-Gomez, et al.
Published: (2025-01-01)

PERK activation mitigates tau pathology in vitro and in vivo
by: Julius Bruch, et al.
Published: (2017-02-01)

Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01)

Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
by: Valeriy Duka, et al.
Published: (2013-01-01)

Immunoelectron microscopy and biochemical studies using three anti-tau antibodies in human brains: associations between pTau and ribosomes
by: Douglas Price, et al.
Published: (2025-07-01)

Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01)

Visualization of the in situ molecular architecture of tau pathology in the murine brain
by: Nedozrálová Hana, et al.
Published: (2024-01-01)

Reversal of neuronal tau pathology via adiponectin receptor activation
by: Eric R. McGregor, et al.
Published: (2025-01-01)

Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
by: Seung‐Hoon Yang, et al.
Published: (2016-11-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

Tau Pathology Drives Disease‐Associated Astrocyte Reactivity in Salt‐Induced Neurodegeneration
by: Tong‐Yu Rui, et al.
Published: (2025-03-01)

T-violating effect in $\nu_\tau (\bar{\nu}_\tau)-$nucleon quasielastic scattering
by: A. Fatima, M. Sajjad Athar and, S. K. Singh
Published: (2025-07-01)

Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology
by: Gege Jiang, et al.
Published: (2025-06-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Piericidin A aggravates Tau pathology in P301S transgenic mice.
by: Matthias Höllerhage, et al.
Published: (2014-01-01)

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
by: Heekyoung Kang, et al.
Published: (2025-08-01)

TauL1, TauL2 and TauL3 gene-pools of Aegilops tauschii essentially differ in their genetic expression patterns
by: Alexander Ju. Dudnikov, et al.
Published: (2024-10-01)

Identification of late-stage tau accumulation using plasma phospho-tau217Research in context
by: Marcel S. Woo, et al.
Published: (2024-11-01)

Discovery and characterization of stereodefined PMO-gapmers targeting tau
by: Kunihiko Kanatsu, et al.
Published: (2025-03-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Fast estimation of Kendall's Tau and conditional Kendall's Tau matrices under structural assumptions
by: van der Spek Rutger, et al.
Published: (2025-04-01)

Retraction: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Published: (2025-01-01)

Predicting regional tau accumulation with machine learning‐based tau‐PET and advanced radiomics
by: Saima Rathore, et al.
Published: (2024-10-01)

Improved reconstruction of highly boosted $$\tau $$ τ -lepton pairs in the $$\tau \tau \rightarrow (\mu \nu _{\mu }\nu _{\tau })(\text {hadrons}+\nu _{\tau })$$ τ τ → ( μ ν μ ν τ ) ( hadrons + ν τ ) decay channels with the ATLAS detector
by: ATLAS Collaboration
Published: (2025-06-01)

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer’s disease mouse models
by: Yongeun Cho, et al.
Published: (2025-12-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)

Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology
by: Zsolt Huszár, et al.
Published: (2024-10-01)

Hyperphosphorylated tau-based Alzheimer’s Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity
by: Hsiao-Tien Hagar, et al.
Published: (2025-06-01)

Long-term X-Ray Variability on the Benchmark YSO HL Tau
by: Steven M. Silverberg, et al.
Published: (2025-01-01)

Strong coupling at the $\tau$-mass scale from an improved vector isovector spectral function
by: Diogo Boito, Maarten Golterman, Kim Maltman, Santiago Peris, Marcus V. Rodrigues, Wilder Schaaf
Published: (2025-07-01)

Activation of the heat shock response as a therapeutic strategy for tau toxicity
by: Taylor R. Stanley, et al.
Published: (2024-09-01)

The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study
by: Marie R. Vermeiren, et al.
Published: (2024-10-01)

Boosted Tau Lepton as a Microscope and Macroscope
by: Sitian Qian, et al.
Published: (2022-01-01)